MAXIPIME FOR INJECTION-PWS IV 2GM
BRISTOL-MYERS SQUIBB CANADA
Quick answers
Is there a shortage of MAXIPIME FOR INJECTION-PWS IV 2GM in Canada?
No. There is no current shortage of MAXIPIME FOR INJECTION-PWS IV 2GM reported to Health Canada. Stock can still vary from one pharmacy to another.
Can I still get this?No shortage reported — confirm local stock with your pharmacy
StatusNo shortage on file
Same-ingredient products on fileNone found
DIN
02163640
Compare with another product →
Product Monograph
Product monograph is not available from Health Canada
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from BRISTOL-MYERS SQUIBB CANADA
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
ABRAXANE FOR INJECTABLE SUSPENSION
100MG · DIN 02281066
BARACLUDE
0.5MG · DIN 02282224
BREYANZI
120000000CELLS · DIN 02527138
CAMZYOS
15MG · DIN 02532573
CAMZYOS
5MG · DIN 02532557
CAMZYOS
2.5MG · DIN 02532549
CAMZYOS
10MG · DIN 02532565
CEENU
100MG · DIN 00360414
CEFZIL POWDER FOR ORAL SUSPENSION-125MG/5ML
125MG · DIN 02163675
CEFZIL POWDER FOR ORAL SUSPENSION-250 MG/ 5 ML
250MG · DIN 02163683
CEFZIL TABLETS - 250MG
250MG · DIN 02163659
CEFZIL TABLETS - 500MG
500MG · DIN 02163667